Doctor profile · Federal record
Dr. Aisha Ahmed, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Tucson, AZ
- NPI 1730341850
- Accepts Medicare
- MIPS 97.2 / 100 · 2023
- 22 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
603 N Wilmot RD Ste 151
Tucson, AZ 857112701
(520) 886-0206
fax (520) 886-0829 - Mailing address
-
Po Box 910221
Dallas, TX 753910221
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- March 18, 2022
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arizona #59154
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1730341850. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
48,011
Distinct HCPCS
10
Medicare allowed
$1,063,610
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 11,100 | 13 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 7,528 | 25 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,490 | 24 | $54 | |
J0185 |
Injection, aprepitant, 1 mg | 5,850 | 32 | $2 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 4,320 | 13 | $46 | |
J0897 |
Injection, denosumab, 1 mg | 1,440 | 16 | $23 | |
Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 1,380 | 13 | $28 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,200 | 13 | $42 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 1,050 | 48 | $0 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 950 | 14 | $28 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 951. This provider delivers 50× the peer median.Open Payments
Industry payments received
All-time total
$2,197
Transactions
97
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $302.55 | |
| Celgene Corporation | 17 | $204.91 | |
| Gilead Sciences, Inc. | 10 | $197.97 | |
| Daiichi Sankyo Inc. | 8 | $171.22 | |
| Incyte Corporation | 5 | $166.38 | |
| Janssen Biotech, Inc. | 4 | $166.17 | |
| PFIZER INC. | 8 | $134.46 | |
| ABBVIE INC. | 4 | $82.03 | |
| Merck Sharp & Dohme LLC | 5 | $78.20 | |
| Genmab U.S., Inc. | 3 | $74.61 | |
| AstraZeneca Pharmaceuticals LP | 3 | $65.81 | |
| Stemline Therapeutics Inc. | 3 | $62.21 | |
| Eisai Inc. | 3 | $58.89 | |
| Lilly USA, LLC | 3 | $46.55 | |
| ARRAY BIOPHARMA INC | 2 | $44.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,430
Patients
464
Total drug cost
$723,741
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 506 | 160 | $14,308 |
| Pantoprazole Sodium | Generic | 205 | 61 | $3,032 |
| Tamoxifen Citrate | Generic | 159 | 58 | $4,788 |
| Gabapentin | Generic | 81 | 25 | $626 |
| Ondansetron Hcl | Generic | 80 | 41 | $925 |
| Citalopram Hbr (Citalopram Hydrobromide) | Brand | 65 | 20 | $362 |
| Dexamethasone | Generic | 49 | 29 | $435 |
| Prochlorperazine Maleate | Generic | 46 | 27 | $684 |
| Verzenio (Abemaciclib) | Brand | 41 | 13 | $669,692 |
| Eliquis (Apixaban) | Brand | 40 | 0 | $24,468 |
Frequently asked questions
What is Dr. Aisha Ahmed's medical specialty?
Dr. Aisha Ahmed practices Hematology & Oncology Physician in Tucson, AZ.
Where does Dr. Aisha Ahmed practice?
Dr. Aisha Ahmed practices at 603 N Wilmot RD Ste 151, Tucson, AZ 857112701. Office phone: 5208860206.
What is Dr. Aisha Ahmed's NPI?
Dr. Aisha Ahmed's National Provider Identifier (NPI) is 1730341850, issued by NPPES.
Does Dr. Aisha Ahmed accept Medicare assignment?
Yes. Dr. Aisha Ahmed accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Aisha Ahmed commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, paclitaxel, 1 mg (HCPCS J9267); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.